Evidence map›Paper›PMID 32230815›Full record

ArticleMolecules (Basel, Switzerland)2020

Cognitive Facilitation and Antioxidant Effects of an Essential Oil Mix on Scopolamine-Induced Amnesia in Rats: Molecular Modeling of In Vitro and In Vivo Approaches.

Razvan Stefan Boiangiu, Ion Brinza, Monica Hancianu, Ilkay Erdogan Orhan, Gokcen Eren, Elife Gündüz, Halis Ertas, Lucian Hritcu, Oana Cioanca

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic Efficacy ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Deciphering Neuroprotective Effect ofCurrent drug targets · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The improvement ofFrontiers in pharmacology · 2022
    Article
  15. Protective effect ofFrontiers in pharmacology · 2022
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Razvan Stefan BoiangiuDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.ORCID 0000-0002-2602-4882
Ion BrinzaDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.
Monica HancianuDepartment of Pharmacognosy, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
Ilkay Erdogan OrhanDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Gokcen ErenDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.ORCID 0000-0002-3420-607X
Elife GündüzTalya Herbal Company, R & D Laboratory, Kepez, 07190 Antalya, Turkey.
Halis ErtasTalya Herbal Company, R & D Laboratory, Kepez, 07190 Antalya, Turkey.
Lucian HritcuDepartment of Biology, Faculty of Biology, Alexandru Ioan Cuza University of Iasi, 700506 Iasi, Romania.ORCID 0000-0001-6981-4174
Oana CioancaDepartment of Pharmacognosy, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.ORCID 0000-0001-9173-4832
Alexandru Ioan Cuza University · ROAntalya IVF · TRGazi University · TRGrigore T. Popa University of Medicine and Pharmacy · RO

Funding

Ministry of Research and Innovation within Program 1 - Development of the national RD system, Subprogram 1.2 - Institutional Performance - RDI excellence funding projects Contract no. 34PFE/19.10.2018
6 · The paper itself

Abstract

The present study investigated the capability of an essential oil mix (MO: 1% and 3%) in ameliorating amnesia and brain oxidative stress in a rat model of scopolamine (Sco) and tried to explore the underlying mechanism. The MO was administered by inhalation to rats once daily for 21 days, while Sco (0.7 mg/kg) treatment was delivered 30 min before behavioral tests. Donepezil (DP: 5 mg/kg) was used as a positive reference drug. The cognitive-enhancing effects of the MO in the Sco rat model were assessed in the Y-maze, radial arm maze (RAM), and novel object recognition (NOR) tests. As identified by gas chromatography-mass spectrometry (GC-MS), the chemical composition of the MO is comprised by limonene (91.11%), followed by γ-terpinene (2.02%), β-myrcene (1.92%), β-pinene (1.76%), α-pinene (1.01%), sabinene (0.67%), linalool (0.55%), cymene (0.53%), and valencene (0.43%). Molecular interactions of limonene as the major compound in MO with the active site of butyrylcholinesterase (BChE) was explored via molecular docking experiments, and Van der Waals (vdW) contacts were observed between limonene and the active site residues SER198, HIS438, LEU286, VAL288, and PHE329. The brain oxidative status and acetylcholinesterase (AChE) and BChE inhibitory activities were also determined. MO reversed Sco-induced memory deficits and brain oxidative stress, along with cholinesterase inhibitory effects, which is an important mechanism in the anti-amnesia effect. Our present findings suggest that MO ameliorated memory impairment induced by Sco via restoration of the cholinergic system activity and brain antioxidant status.

Indexed as

AcetylcholinesteraseAmnesiaAnimalsAntioxidantsBehavior Rating ScaleBrainButyrylcholinesteraseCholinesterase InhibitorsCognitionDisease Models, AnimalDonepezilGas Chromatography-Mass SpectrometryInhibitory Concentration 50LimoneneMaleMemory DisordersAcetylcholinesteraseAntioxidantsButyrylcholinesteraseCholinesterase InhibitorsDonepezilLimoneneOils, VolatileScopolamineessential oil mixmemorymolecular docking simulationoxidative stressscopolamine

Identifiers

PMID32230815
PMCPMC7181224
OpenAlexW3013423265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.